Indigenco Pharmaceuticals Pvt Ltd
About Indigenco Pharmaceuticals Pvt Ltd
Data last updated:
Indigenco Pharmaceuticals Pvt Ltd is a private limited company based in Hooghly, West Bengal, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 15 April 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24234WB1986PTC040521. Its GSTIN is 19AABCI1161Q1Z9 (West Bengal).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bijan Mukherjee (Managing Director) and Antara Mukherjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at More Pukur Dakshinpararishra, Hooghly, West Bengal, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹51,457. For the same year it recorded a net loss of ₹15,011 (net margin -29.2%) and EBITDA of -₹5,129 (EBITDA margin -10%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 21% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Indigenco Pharmaceuticals Pvt Ltd's registered office is in Hooghly, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMore Pukur Dakshinpararishra, Hooghly, West Bengal, India
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Indigenco Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indigenco Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indigenco Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Indigenco Pharmaceuticals Pvt Ltd
FY 2025 filings availableIndigenco Pharmaceuticals Pvt Ltd reported revenue of ₹51,457 for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 21% over five years. EBITDA rose 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5,129 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹15,011 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10% | ||||
| Net Profit Margin | -29.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indigenco Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Indigenco Pharmaceuticals Pvt Ltd
Indigenco Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bijan Mukherjee | Managing Director | 15 Apr 1986 | 40 Years 6 Months | Current |
| Antara Mukherjee | Director | 15 Apr 1986 | 40 Years 6 Months | Current |
| Sushrut Mukherjee | Director | 04 Mar 2025 | 1 Years 7 Months | Current |
Shareholding
The shareholding of Indigenco Pharmaceuticals Pvt Ltd is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Indigenco Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Indigenco Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indigenco Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indigenco Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCI1161Q1Z9 | West Bengal | Active | 25 Oct 2017 |
To see the full GST registrations and return filing status of Indigenco Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Indigenco Pharmaceuticals Pvt Ltd has 4 board changes on record since 1986: 3 appointments and 1 cessation. The latest: Sushrut Mukherjee was appointed as Director on 04 Mar 2025.
Frequently asked questions
Indigenco Pharmaceuticals is an active private limited company based in Hooghly, West Bengal, India. The company works in chemical products, within the chemicals industry. It was incorporated on 15 April 1986 (40+ years old) and is registered under CIN U24234WB1986PTC040521.
Indigenco Pharmaceuticals has 3 current directors:
- Bijan Mukherjee - Managing Director
- Antara Mukherjee - Director
- Sushrut Mukherjee - Director
The latest financial statements of Indigenco Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Indigenco Pharmaceuticals is 19AABCI1161Q1Z9, registered in West Bengal.
The CIN (Corporate Identification Number) of Indigenco Pharmaceuticals is U24234WB1986PTC040521. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indigenco Pharmaceuticals was incorporated on 15 April 1986, making it 40+ years old. It is registered with the Registrar of Companies, Kolkata.
Sushrut Mukherjee was appointed as Director on 04 Mar 2025. Bijan Mukherjee ceased to be Director on 22 Nov 2013. Antara Mukherjee was appointed as Director on 15 Apr 1986. Indigenco Pharmaceuticals has 4 board changes on record in total.
The registered office of Indigenco Pharmaceuticals is at More Pukur Dakshinpararishra, Hooghly, West Bengal, India.
Indigenco Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Indigenco Pharmaceuticals is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
